Imunon, Inc.Insider Ownership
|
|
Current Insider Ownership
Log in to see the full results
Login or create a free CapEdge account to unlock the rest of this table.
| Lindborg Stacy | President and CEO | Common StockImunon Common StockRestricted Stock UnitsStock Option (Right to Buy) | Jul 2, 2026Aug 15, 2024Sep 6, 2024Jan 2, 2026 | 76,722264,16625,000828,619 | 3.0410.480.9932.87 | 140,401483,42445,7501,516,373 |
| Tardugno Michael H | Executive Chairman of Board | Common StockImunon Common StockStock Option (Right to Buy) | Jul 2, 2026Aug 15, 2024Jan 2, 2026 | 64,396353,3461,250,285 | 2.5514.0149.59 | 117,845646,6232,288,022 |
| Faller Douglas Vincent | Chief Medical Officer | Common StockStock Option (Right to Buy) | Jul 2, 2026Jan 2, 2026 | 23,204112,667 | 0.924.47 | 42,463206,181 |
Insider Trading Trends
Insider Transactions
Voluntary Buys vs Sells
You need to login to see this data
Historical Insider Trading (3-Years)
10b5-1
Log in to see the full results
Login or create a free CapEdge account to unlock the rest of this table.
| Eylward Susan | Common Stock | No | No | Sell | DISPOSE S | 1.88 | -920 | 1,730 | 2,896 | Jul 6, 2026 | |
| Faller Douglas Vincent | Common Stock | No | No | Grant | ACQUIRE A | 1.91 | +1,308 | 2,498 | 23,204 | Jul 2, 2026 | |
| Lindborg Stacy | Common Stock | No | No | Grant | ACQUIRE A | 1.91 | +2,534 | 4,840 | 76,722 | Jul 2, 2026 | |